TP53 and nasopharyngeal carcinoma: In conclusion, this study has demonstrated for the first time that EGCG could activate the mitochondrial apoptotic pathway by inhibiting the SIRT1-p53 signaling pathway and finally inducing the apoptosis in human NPC cell lines (Figure 8).